These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7585729)

  • 1. IgD myeloma: clinical characteristics and a new staging system based on analysis of Japanese patients.
    Shimamoto Y
    Cancer Detect Prev; 1995; 19(5):426-35. PubMed ID: 7585729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
    Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
    Tao ZF; Fu WJ; Chen YB; Yuan ZG; Wang DX; Hou J
    Ai Zheng; 2006 Apr; 25(4):461-4. PubMed ID: 16613681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International staging system for multiple myeloma.
    Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J
    J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic evaluation in multiple myeloma. Relationship between immunological types, single prognostic factors, clinical staging systems, morphological classification systems and survival].
    Pasqualetti P; Colantonio D; Casale R; Di Lauro G; Collacciani A; Festuccia V; Trotta A; Natali G
    Ann Ital Med Int; 1990; 5(3 Pt 1):195-204. PubMed ID: 2288822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-image cytometry and clinical staging systems in multiple myeloma.
    Kropff M; Leo E; Steinfurth G; Esselborn H; Adler CP; Böcking A
    Anticancer Res; 1994; 14(5B):2183-8. PubMed ID: 7840520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin D myeloma--problems with diagnosing and staging (own experience and literature review).
    Kuliszkiewicz-Janus M; Zimny A; Sokolska V; Saşiadek M; Kuliczkowski K
    Leuk Lymphoma; 2005 Jul; 46(7):1029-37. PubMed ID: 16019554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors of multiple myeloma].
    Paule B
    Ann Med Interne (Paris); 1997; 148(8):534-41. PubMed ID: 9538400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two staging systems for myeloma.
    Vercelli D; Cozzolino F; Di Guglielmo R
    Nouv Rev Fr Hematol (1978); 1981; 23(2):107-10. PubMed ID: 7290984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in multiple myeloma: selection using Cox's proportional hazard model.
    Pasqualetti P; Collacciani A; Maccarone C; Casale R
    Biomed Pharmacother; 1996; 50(1):29-35. PubMed ID: 8672729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of cyclooxygenase-2 in multiple myeloma: association with reduced survival.
    Cetin M; Buyukberber S; Demir M; Sari I; Sari I; Deniz K; Eser B; Altuntas F; Camci C; Oztürk A; Turgut B; Vural O; Unal A
    Am J Hematol; 2005 Nov; 80(3):169-73. PubMed ID: 16247750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple prognostic model for patients with multiple myeloma: a single-center study in Japan.
    Kaneko M; Kanda Y; Oshima K; Nannya Y; Suguro M; Yamamoto R; Chizuka A; Hamaki T; Matsuyama T; Takezako N; Miwa A; Togawa A
    Ann Hematol; 2002 Jan; 81(1):33-6. PubMed ID: 11807633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New staging systems can predict prognosis of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation as first-line therapy.
    Kim H; Sohn HJ; Kim S; Kim K; Lee JH; Bang SM; Kim DH; Sohn SK; Lee JJ; Suh C
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):837-44. PubMed ID: 16864054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma in the region of Bursa, Turkey: a retrospective analysis.
    Ozkalemkaş F; Ali R; Tunali A; Ozkocaman V; Ozyardimci C; Ozçelik T
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):267-70. PubMed ID: 9216819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.